HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differences in cerebral blood flow and glucose utilization in vegetative versus locked-in patients.

Abstract
Positron emission tomographic studies of regional cerebral metabolic rate for glucose (rCMRGlc) and cerebral blood flow were performed in 7 vegetative and 3 locked-in patients to determine objectively the level of brain function underlying these clinical states. Cortical gray rCMRGlc in the vegetative patients was 2.73 +/- 0.13 (mean +/- SEM) mg/100 gm/min, less than half the normal value of 6.82 +/- 0.23 (p less than 0.001). Cerebral blood flow exhibited similar but more variable reductions. By contrast, cortical rCMRGlc in the locked-in patients was 5.08 +/- 0.69, a 25% reduction (p less than 0.02) from normal. The massive reduction in vegetative rCMRGlc involved not only the cerebral cortex but also the basal nuclei and cerebellum. Such metabolic hypoactivity has precedent only in deep anesthesia and supports clinical evidence that cerebral cognitive function is lost in the vegetative state, leaving a body that can no longer think or experience pain.
AuthorsD E Levy, J J Sidtis, D A Rottenberg, J O Jarden, S C Strother, V Dhawan, J Z Ginos, M J Tramo, A C Evans, F Plum
JournalAnnals of neurology (Ann Neurol) Vol. 22 Issue 6 Pg. 673-82 (Dec 1987) ISSN: 0364-5134 [Print] United States
PMID3501694 (Publication Type: Case Reports, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fluorodeoxyglucose F18
  • Deoxyglucose
  • Glucose
Topics
  • Adolescent
  • Adult
  • Brain Diseases (diagnostic imaging, metabolism, physiopathology)
  • Cerebrovascular Circulation
  • Coma (diagnostic imaging, metabolism, physiopathology)
  • Deoxyglucose (analogs & derivatives)
  • Female
  • Fluorodeoxyglucose F18
  • Glucose (metabolism)
  • Humans
  • Male
  • Middle Aged
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: